Identifying cardiovascular risk: Cardea 20/20 ECG™
Sudden Cardiac Arrest is the number one medical cause of death in athletes during sports. Yet current ECG algorithms are not tuned to the normal range of conditions present in athletes, resulting in high false-positive findings and unnecessary medical expenses associated with follow-up diagnostic tests.
-~2% false positives: the industry’s lowest compared to an historical false-positive rate of up to 30% in other devices
-Breakthrough Interpretation: only system automated with International Criteria
-Better Analysis: high ECG sample rate, industry-leading signal resolution and extended recording time ensure accuracy
-Reduced Costs: low false positives limits unnecessary follow-up testing
-Portable: lightweight ECG transmitter connects via USB cable to standard Windows® PC and can easily be transported to multiple locations
-Collaborative: robust ECG editing and analysis tools for physician over-reads
-Cloud-Based Storage Supported: save and share data
Brands: Cardiac Insight, Cardea 20/20 ECG™, Cardea SOLO™ ECG System